Physiological rationale for co-treatment with diuretics in heart failure
Open Access
- 1 August 1994
- Vol. 72 (2 Suppl) , S63-S67
- https://doi.org/10.1136/hrt.72.2_suppl.s63
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Beneficial effects of pimobendan on exercise tolerance and quality of life in patients with heart failure. Results of a multicenter trial. The Pimobendan Multicenter Research Group.Circulation, 1992
- Atrial natriuretic factor in normal subjects and heart failure patients. Plasma levels and renal, hormonal, and hemodynamic responses to peptide infusion.Journal of Clinical Investigation, 1986
- Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart FailureNew England Journal of Medicine, 1986
- Vascular hemodynamic impedance in congestive heart failureThe American Journal of Cardiology, 1985
- Increased plasma arginine vasopressin levels in patients with congestive heart failureJournal of the American College of Cardiology, 1983
- Improved exercise capacity and differing arterial and venous tolerance during chronic isosorbide dinitrate therapy for congestive heart failure.Circulation, 1983
- Activity of the sympathetic nervous system and renin-angiotensin system assessed by plasma hormone levels and their relation to hemodynamic abnormalities in congestive heart failureThe American Journal of Cardiology, 1982
- Contrasting immediate and long-term effects of isosorbide dinitrate on exercise capacity in congestive heart failureThe American Journal of Medicine, 1980
- Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy.Heart, 1975
- Treadmill exercise in assessment of the functional capacity of patients with cardiac diseaseThe American Journal of Cardiology, 1972